Sank Leonard has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 30000 shares of ORAMED PHARMACEUTICALS INC. ($ORMP) on June 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Sank Leonard | Director | A | Common Stock | 30000 | $0.00 | 128,021.0000 | 41,228,782 | 30.61% | 0.07% |
| June 5, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Sank Leonard | Director | A | Common Stock | 6510 | $0.00 | 134,531.0000 | 41,228,782 | 5.09% | 0.02% |
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Sank Leonard | Director | A | Common Stock | 30000 | $0.00 | 88,696.0000 | 40,566,901 | 51.11% | 0.07% |
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Sank Leonard | Director | A | Common Stock | 9325 | $0.00 | 98,021.0000 | 40,566,901 | 10.51% | 0.02% |